NIH Study Suggests Aspirin Use Protects From ER-Positive Breast Cancer
This article was originally published in The Tan Sheet
Executive Summary
Nonsteroidal anti-inflammatory drugs do not influence total breast cancer risk, but daily aspirin use appears to offer some protection from a type of the condition - estrogen receptor-positive - that responds to hormonal treatment, according to a National Institutes of Health study
You may also be interested in...
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
Sure Nature Can “Kiss” ImmunaSure Ad Goodbye – NAD
Sure Nature claims its ImmunaSure dietary supplement can help "kiss your cold sores goodbye," but the National Advertising Division does not embrace the pitch